Make big pharma squirm. Sell this company to China.
Company's value is in how much they will save countries like China.
Brazil is already in the game. They will no longer allow themselves to be ripped off by big pharma.
Big pharma pays the generics makers to delay bringing generics to market. Countries like Brazil get screwed. Time to beat them at their own game. Brazilian government and Chinese government buy the technology and auto-approve every drug that the governments makes generics of.
10-K says Aviezer's 2013 salary was $527,672, including bonuses he was compensated $1.77 million. The rest of top management all get paid between $230,000 to $302,000, including the bonuses, they made $600,000 to $1 million. Anyway, hope they can get partners to speed up development of other drugs and drug classes such as "enzymes, hormones, monoclonal antibodies, cytokines and vaccines."